These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11071968

  • 1. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis.
    Zarif L, Covic A, Iyengar S, Sehgal AR, Sedor JR, Schelling JR.
    Nephrol Dial Transplant; 2000 Nov; 15(11):1801-7. PubMed ID: 11071968
    [Abstract] [Full Text] [Related]

  • 2. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI, Hewan-Lowe K.
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.
    Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R.
    Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739
    [Abstract] [Full Text] [Related]

  • 7. The familial risk of end-stage renal disease in African Americans.
    Freedman BI, Spray BJ, Tuttle AB, Buckalew VM.
    Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
    Liang S, Le W, Liang D, Chen H, Xu F, Chen H, Liu Z, Zeng C.
    BMC Nephrol; 2016 Apr 11; 17():42. PubMed ID: 27066888
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
    Hirakawa S, Lange EM, Colicigno CJ, Freedman BI, Rich SS, Bowden DW.
    Am J Kidney Dis; 2003 Jul 11; 42(1):133-42. PubMed ID: 12830465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical documentation of end-stage renal disease due to hypertension.
    Schlessinger SD, Tankersley MR, Curtis JJ.
    Am J Kidney Dis; 1994 May 11; 23(5):655-60. PubMed ID: 8172207
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hypertensive nephrosclerosis].
    Krummel T, Bazin D, Faller AL, Hannedouche T.
    Presse Med; 2012 Feb 11; 41(2):116-24. PubMed ID: 21641755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The MTHFR 677TT and 677CT/1298AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure.
    Koupepidou P, Deltas C, Christofides TC, Athanasiou Y, Zouvani I, Pierides A.
    Int Angiol; 2005 Sep 11; 24(3):287-94. PubMed ID: 16158041
    [Abstract] [Full Text] [Related]

  • 20. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA, Ng MC, Palmer ND, Keaton JM, Larsen CP, Hicks PJ, T2D-GENES Consortium, Langefeld CD, Freedman BI, Bowden DW.
    Clin J Am Soc Nephrol; 2014 Aug 07; 9(8):1434-40. PubMed ID: 24948143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.